vs
LandBridge Co LLC（LB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是LandBridge Co LLC的1.3倍（$75.5M vs $56.8M），LandBridge Co LLC同比增速更快（55.6% vs 27.7%），LandBridge Co LLC自由现金流更多（$122.0M vs $14.4M），过去两年LandBridge Co LLC的营收复合增速更高（72.8% vs 31.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$56.8M
营收增速更快
LB
高出27.8%
27.7%
自由现金流更多
LB
多$107.7M
$14.4M
两年增速更快
LB
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.8M | $75.5M |
| 净利润 | $8.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 60.0% | 22.7% |
| 净利率 | 14.2% | — |
| 营收同比 | 55.6% | 27.7% |
| 净利润同比 | -83.7% | — |
| 每股收益（稀释后） | $0.24 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LBPBYI
| Q4 25 | $56.8M | $75.5M | ||
| Q3 25 | $50.8M | $54.5M | ||
| Q2 25 | $47.5M | $52.4M | ||
| Q1 25 | $44.0M | $46.0M | ||
| Q4 24 | $36.5M | $59.1M | ||
| Q3 24 | $28.5M | $80.5M | ||
| Q2 24 | $26.0M | $47.1M | ||
| Q1 24 | $19.0M | $43.8M |
净利润LBPBYI
| Q4 25 | $8.1M | — | ||
| Q3 25 | $8.1M | $8.8M | ||
| Q2 25 | $7.5M | $5.9M | ||
| Q1 25 | $6.5M | $3.0M | ||
| Q4 24 | $49.3M | — | ||
| Q3 24 | $2.7M | $20.3M | ||
| Q2 24 | $-57.7M | $-4.5M | ||
| Q1 24 | $10.8M | $-4.8M |
毛利率LBPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率LBPBYI
| Q4 25 | 60.0% | 22.7% | ||
| Q3 25 | 60.8% | 17.6% | ||
| Q2 25 | 60.0% | 12.7% | ||
| Q1 25 | 57.0% | 8.7% | ||
| Q4 24 | 49.4% | 22.6% | ||
| Q3 24 | 11.2% | 27.4% | ||
| Q2 24 | -197.4% | -4.6% | ||
| Q1 24 | 71.1% | -5.3% |
净利率LBPBYI
| Q4 25 | 14.2% | — | ||
| Q3 25 | 15.9% | 16.2% | ||
| Q2 25 | 15.8% | 11.2% | ||
| Q1 25 | 14.7% | 6.5% | ||
| Q4 24 | 135.2% | — | ||
| Q3 24 | 9.3% | 25.2% | ||
| Q2 24 | -222.1% | -9.6% | ||
| Q1 24 | 56.7% | -11.0% |
每股收益（稀释后）LBPBYI
| Q4 25 | $0.24 | $0.26 | ||
| Q3 25 | $0.26 | $0.17 | ||
| Q2 25 | $0.24 | $0.12 | ||
| Q1 25 | $0.20 | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $-0.04 | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.7M | $97.5M |
| 总债务越低越好 | $570.7M | $22.7M |
| 股东权益账面价值 | $340.3M | $130.3M |
| 总资产 | $1.4B | $216.3M |
| 负债/权益比越低杠杆越低 | 1.68× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LBPBYI
| Q4 25 | $30.7M | $97.5M | ||
| Q3 25 | $28.3M | $94.4M | ||
| Q2 25 | $20.3M | $96.0M | ||
| Q1 25 | $14.9M | $93.2M | ||
| Q4 24 | $37.0M | $101.0M | ||
| Q3 24 | $14.4M | $96.7M | ||
| Q2 24 | $24.6M | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务LBPBYI
| Q4 25 | $570.7M | $22.7M | ||
| Q3 25 | $366.1M | $34.0M | ||
| Q2 25 | $370.9M | $45.3M | ||
| Q1 25 | $375.5M | $56.7M | ||
| Q4 24 | $385.5M | $68.0M | ||
| Q3 24 | $242.4M | $79.3M | ||
| Q2 24 | $360.8M | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益LBPBYI
| Q4 25 | $340.3M | $130.3M | ||
| Q3 25 | $272.0M | $115.3M | ||
| Q2 25 | $266.4M | $104.7M | ||
| Q1 25 | $217.0M | $97.1M | ||
| Q4 24 | $211.8M | $92.1M | ||
| Q3 24 | $97.2M | $71.1M | ||
| Q2 24 | $296.4M | $48.5M | ||
| Q1 24 | $162.3M | $51.0M |
总资产LBPBYI
| Q4 25 | $1.4B | $216.3M | ||
| Q3 25 | $1.1B | $202.9M | ||
| Q2 25 | $1.1B | $194.9M | ||
| Q1 25 | $1.0B | $196.2M | ||
| Q4 24 | $1.0B | $213.3M | ||
| Q3 24 | $689.9M | $220.7M | ||
| Q2 24 | $710.5M | $205.0M | ||
| Q1 24 | — | $214.1M |
负债/权益比LBPBYI
| Q4 25 | 1.68× | 0.17× | ||
| Q3 25 | 1.35× | 0.30× | ||
| Q2 25 | 1.39× | 0.43× | ||
| Q1 25 | 1.73× | 0.58× | ||
| Q4 24 | 1.82× | 0.74× | ||
| Q3 24 | 2.49× | 1.12× | ||
| Q2 24 | 1.22× | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $122.0M | $14.4M |
| 自由现金流率自由现金流/营收 | 214.9% | 19.1% |
| 资本支出强度资本支出/营收 | 7.5% | 0.0% |
| 现金转化率经营现金流/净利润 | 15.68× | — |
| 过去12个月自由现金流最近4个季度 | $207.7M | $41.7M |
8季度趋势，按日历期对齐
经营现金流LBPBYI
| Q4 25 | $126.3M | $14.4M | ||
| Q3 25 | $34.9M | $9.7M | ||
| Q2 25 | $37.3M | $14.1M | ||
| Q1 25 | $15.9M | $3.6M | ||
| Q4 24 | $67.6M | $15.6M | ||
| Q3 24 | $7.5M | $11.0M | ||
| Q2 24 | $16.0M | $1.0M | ||
| Q1 24 | $17.2M | $11.2M |
自由现金流LBPBYI
| Q4 25 | $122.0M | $14.4M | ||
| Q3 25 | $33.7M | $9.7M | ||
| Q2 25 | $36.1M | $14.1M | ||
| Q1 25 | $15.8M | $3.6M | ||
| Q4 24 | $66.7M | $15.6M | ||
| Q3 24 | $7.1M | $11.0M | ||
| Q2 24 | $15.7M | $1.0M | ||
| Q1 24 | $17.1M | — |
自由现金流率LBPBYI
| Q4 25 | 214.9% | 19.1% | ||
| Q3 25 | 66.3% | 17.7% | ||
| Q2 25 | 75.9% | 26.8% | ||
| Q1 25 | 36.0% | 7.7% | ||
| Q4 24 | 182.6% | 26.4% | ||
| Q3 24 | 25.1% | 13.7% | ||
| Q2 24 | 60.4% | 2.1% | ||
| Q1 24 | 90.1% | — |
资本支出强度LBPBYI
| Q4 25 | 7.5% | 0.0% | ||
| Q3 25 | 2.3% | 0.0% | ||
| Q2 25 | 2.6% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 2.7% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 0.5% | 0.0% |
现金转化率LBPBYI
| Q4 25 | 15.68× | — | ||
| Q3 25 | 4.31× | 1.10× | ||
| Q2 25 | 4.98× | 2.41× | ||
| Q1 25 | 2.46× | 1.21× | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 2.80× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
